Concerns about health care inequities and the medtech sector’s environmental impacts have spiked during the COVID crisis, and they are not likely to subside with the end of the pandemic, industry leaders say.
“We’re learning, we’re developing principles, and we’re trying to problem-solve together,” said Mike Mussallem, CEO of Edwards Lifesciences Corp., during a panel discussion at AdvaMed’s recent MedTech Conference that...